"The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart "...
(phenylephrine hydrochloride) Ophthalmic Solution, USP
Vasoconstrictor and Mydriatic Solutions 2.5% AND 10%
Viscous Solution 10%
For Use in Ophthalmology
PHYSICIANS SHOULD COMPLETELY FAMILIARIZE THEMSELVES WITH THE COMPLETE CONTENTS OF THIS LEAFLET BEFORE PRESCRIBING NEO-SYNEPHRINE (phenylephrine hydrochloride ophthalmic solution)
NEO-SYNEPHRINE hydrochloride, brand of phenylephrine hydrochloride ophthalmic solution, is a sterile solution used as a vasoconstrictor and mydriatic for use in ophthalmology.
NEO-SYNEPHRINE (phenylephrine hydrochloride ophthalmic solution) hydrochloride is a synthetic sympathomimetic compound structurally similar to epinephrine and ephedrine.
Phenylephrine hydrochloride is ( - )-m- Hydroxy- α- [(methylamino)methyl] benzyl alcohol hydrochloride, and has the following structural formula:
What are the possible side effects of phenylephrine ophthalmic?
If you experience any of the following serious side effects, stop using phenylephrine ophthalmic and seek emergency medical attention or contact your doctor immediately:
- an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, face, or tongue; or hives);
- an irregular or fast heart rate; or
- high blood pressure (severe headache, blurred vision, or flushed skin).
Other, less serious side effects may be more likely to occur. Continue to use phenylephrine ophthalmic and talk to your doctor if you...
Last reviewed on RxList: 5/6/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Neo-Synephrine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.